A carregar...
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy
Despite lengthening survival, death rates from metastatic colorectal cancer (CRC) remain unacceptably high, with a bright spot being the demonstration of durable responses in patients with CRC who have mismatch repair‐deficient (dMMR) and/or microsatellite instability‐high (MSI‐H) tumors and are tre...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6964145/ https://ncbi.nlm.nih.gov/pubmed/31383813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0176 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|